Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News

Advances in rheumatoid arthritis pathogenesis ‘nothing short of extraordinary’
Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the groundwork that may inform a new generation of therapeutic targets and therapies.
Cycling JAKi after poor response in rheumatoid arthritis better than switching to bDMARD

For patients with rheumatoid arthritis and inadequate response to JAK inhibitors, cycling to another JAK inhibitor is a more effective option than switching to a biological disease-modifying antirheumatic drug, according to data.
Lack of adequate mental health care in inflammatory arthritis ‘needs to be addressed’

Depression and anxiety among patients with inflammatory arthritis is significantly undertreated, with large proportions not receiving minimally adequate care, according to data published in Arthritis Research & Therapy.
Log in or Sign up for Free to view tailored content for your specialty!
TNF inhibitors do not increase adverse event risk in rheumatoid arthritis-associated ILD

Treatment with TNF inhibitors yielded no differences in outcomes vs. other antirheumatic therapies among U.S. veterans with rheumatoid arthritis-associated interstitial lung disease, according to data published in The Lancet Rheumatology.
FDA approves third Actemra biosimilar; second available in intravenous, subcutaneous forms

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.
Rheumatoid refresher: Top news you may have missed for Rheumatoid Awareness Day

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of rheumatoid arthritis, a chronic autoimmune disease that affects about 1.5 million people in the United States.
Anti-inflammatory therapies linked to reduced risk, incidence of Parkinson’s disease

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was associated with reduced incidence of Parkinson’s disease, data show.
Exposure to nitrogen oxides, particulate matter increase risk for autoimmune disease

Exposure to various air pollutants, such as PM2.5 and nitrogen oxides, increases the risk for several autoimmune diseases, including psoriasis, lupus and rheumatoid arthritis, according to data published in Scientific Reports.
Odds of DMARD-free remission in rheumatoid arthritis may depend on biological DMARD use

Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with rheumatoid arthritis requiring biological DMARDs, it is possible for those who do not require them, according to data.
EULAR: Start inflammatory arthritis therapies ‘without delay’ after cancer remission

Targeted therapies for active inflammatory arthritis should be started “without delay” for patients with cancer in remission, according to new EULAR points to consider published in Annals of the Rheumatic Diseases.
-
Headline News
Veterinarians had undetected bird flu infections, but such cases are rare, CDC says
February 19, 20252 min read -
Headline News
Semaglutide may raise risk for form of optic neuropathy in adults with type 2 diabetes
February 20, 20253 min read -
Headline News
CDC disease detectives ‘remain in their positions,’ agency says
February 20, 20253 min read
-
Headline News
Veterinarians had undetected bird flu infections, but such cases are rare, CDC says
February 19, 20252 min read -
Headline News
Semaglutide may raise risk for form of optic neuropathy in adults with type 2 diabetes
February 20, 20253 min read -
Headline News
CDC disease detectives ‘remain in their positions,’ agency says
February 20, 20253 min read